全文获取类型
收费全文 | 8406篇 |
免费 | 348篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 202篇 |
儿科学 | 168篇 |
妇产科学 | 123篇 |
基础医学 | 1691篇 |
口腔科学 | 172篇 |
临床医学 | 592篇 |
内科学 | 1411篇 |
皮肤病学 | 479篇 |
神经病学 | 829篇 |
特种医学 | 289篇 |
外科学 | 1106篇 |
综合类 | 60篇 |
一般理论 | 3篇 |
预防医学 | 383篇 |
眼科学 | 194篇 |
药学 | 610篇 |
中国医学 | 24篇 |
肿瘤学 | 442篇 |
出版年
2022年 | 61篇 |
2021年 | 100篇 |
2020年 | 96篇 |
2019年 | 94篇 |
2018年 | 126篇 |
2017年 | 103篇 |
2016年 | 117篇 |
2015年 | 143篇 |
2014年 | 183篇 |
2013年 | 220篇 |
2012年 | 358篇 |
2011年 | 405篇 |
2010年 | 267篇 |
2009年 | 237篇 |
2008年 | 391篇 |
2007年 | 427篇 |
2006年 | 400篇 |
2005年 | 432篇 |
2004年 | 387篇 |
2003年 | 372篇 |
2002年 | 423篇 |
2001年 | 105篇 |
2000年 | 95篇 |
1999年 | 122篇 |
1998年 | 103篇 |
1997年 | 107篇 |
1996年 | 75篇 |
1995年 | 59篇 |
1994年 | 62篇 |
1993年 | 50篇 |
1992年 | 59篇 |
1991年 | 48篇 |
1989年 | 44篇 |
1988年 | 44篇 |
1987年 | 45篇 |
1985年 | 57篇 |
1982年 | 46篇 |
1976年 | 42篇 |
1940年 | 44篇 |
1939年 | 58篇 |
1938年 | 54篇 |
1937年 | 43篇 |
1932年 | 48篇 |
1930年 | 48篇 |
1928年 | 58篇 |
1927年 | 48篇 |
1926年 | 49篇 |
1925年 | 46篇 |
1922年 | 42篇 |
1913年 | 49篇 |
排序方式: 共有8778条查询结果,搜索用时 0 毫秒
1.
2.
Johannes Woitzik Elke Lassel Ulf C. Schneider Helmut Schroeck Rudolf Graf 《Experimental neurology》2009,218(1):41-350
Lesion evolution during focal cerebral ischemia may depend on flow restrictions or on accumulation of toxic mediators within the infarct and expansion of these factors to the periinfarct region. So far, the precise contribution of flow dependent versus spreading-mediated impairment of viable periinfarct tissue has not been determined. Therefore, we measured lesion expansion, flow restrictions and glutamate distribution on serial brain sections at different time points after experimental focal ischemia.Permanent focal ischemia was induced by occlusion of the right middle cerebral artery in male rats and the flow reduction was subsequently measured at 1, 12 and 24 h using iodo[14C]antipyrine autoradiography. Additionally, the necrotic volume was determined on serial brain sections and the glutamate content was measured in tissue samples from adjacent microdissections.Twelve hours after focal ischemia no noteworthy viable areas with blood flow restrictions of 20-40 ml 100 g− 1 min− 1 existed but at 24 h the necrotic tissue exceeded the hemodynamically compromised region by 40 ± 21 mm3 (24%). Furthermore, at 12 and 24 h the glutamate content was elevated in areas surrounding the infarct.Relevant flow restrictions are detectable only during early stages of infarct maturation, whereas the propagation of secondary factors may be the predominant mechanism for delayed infarct evolution. 相似文献
3.
4.
5.
6.
Does Additional Doxorubicin Chemotherapy Improve Outcome in Patients with Hepatocellular Carcinoma Treated by Liver Transplantation? 总被引:5,自引:0,他引:5
Herwig Pokorny Michael Gnant Susanne Rasoul-Rockenschaub Bernd Gollackner Birgit Steiner Günter Steger Rudolf Steininger Ferdinand Mühlbacher 《American journal of transplantation》2005,5(4):788-794
The aim of this prospective randomized study was to determine whether additional doxorubicin chemotherapy improves outcome in patients with hepatocellular carcinoma (HCCA) treated by liver transplantation. Stratification parameters were tumor stage (UICC I-IVa), gender, age 50 years, α-fetoprotein 20 ng/mL, cirrhosis and HbsAg status. For pre-operative chemotherapy doxorubicin (15 mg/m2 ) was given biweekly, intra-operative chemotherapy was a single dose administered before surgical manipulation. Post-operative chemotherapy from day 10 was as given preoperatively for a total dosage of 300 mg/m2 . Outcome parameters were overall survival (OS) and disease-free survival. Of the 75 consecutive patients who received liver transplantation for treatment of HCCA, 62 patients were enrolled. Thirty-four patients were randomized in the chemotherapy group; 28 patients were in the control group and transplanted only. OS rates at 5 years were 38% in the chemotherapy group and 40% in the control group, disease-free survival rates at 5 years 43% and 53%, respectively. Tumor stage and vascular invasion were identified as independent risk factors for recurrence of disease. Doxorubicin chemotherapy did not improve organ survival and disease-free survival in patients undergoing liver transplantation for HCCA. 相似文献
7.
Qiang Tan Rudolf Steiner Simon P Hoerstrup Walter Weder 《European journal of cardio-thoracic surgery》2006,30(5):782-786
This review tries to summarize the efforts over the past 20 years to construct a tissue-engineered trachea. After illustrating the main technical bottlenecks faced nowadays, we discuss what might be the solutions to these bottlenecks. You may find out why the focus in this research field shifts dramatically from the construction of a tubular cartilage tissue to reepithelialization and revascularization of the prosthesis. In the end we propose a novel concept of 'in vivo bioreactor', defined as the design of a perfusion system inside the scaffold, and explain its potential application in the construction of a tissue-engineered trachea. 相似文献
8.
Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression 总被引:2,自引:0,他引:2
R. Bottlender Daniel Rudolf Anton Strauss Hans-Jürgen Möller 《European archives of psychiatry and clinical neuroscience》1998,248(6):296-300
Medical records of 158 patients with bipolar depression were analysed for the incidence of a switch from depression to maniform
states (mania and hypomania). Relation to psychopharmacological treatment was investigated. Thirty-nine (25%) patients of
the total sample had switched to a maniform state during the treatment period in the hospital. Among that group the phenomenon
occurred in 23 patients (15%) as a hypomania and in 16 patients (10%) as a mania. Patients with a switch were significantly
more often treated with tricyclic antidepressants (TCA) than patients without switch (79.5% vs 51.3%). Mood stabilising medication
might reduce the risk for switching, especially in patients treated with TCA; however, it seems not totally sufficient, since
59% of the switched patients received mood stabilisers. The switch phenomenon was not associated with sociodemographic or
clinical data.
Received: 23 September 1998 / Accepted: 28 September 1998 相似文献
9.
10.
Friedrich Längle M.D. Thomas Soliman M.D. Nikolaus Neuhold M.D. Gerold Widhalm M.D. Bruno Niederle M.D. Sebastian Roka K. Kaserer M.D. Wolfgang Blauensteiner M.D. Karl Dam M.D. Martin Clodi M.D. Juan Flores M.D. Almute Loidl M.D. Bernhard Schwarzlmüller M.D. Eva Huber M.D. Gerald Jahl Klaus Wamprechtshammer Rudolf Roka M.D. 《World journal of surgery》1994,18(4):583-587
Patients treated for sporadic and hereditary medullary thyroid carcinoma (MTC) have varying rates of persistent disease, recurrence, and survival. The aim of this study was to correlate the immunoreactivity of the monoclonal antibody CD15 (LeuM1) to initial clinical findings and the outcome of treatment. The primary tumors of 75 patients with sporadic MTC, 7 with hereditary disease, and 3 members of MEN 2A families were studied. Of these subjects 74 (87%) showed no or little immunoreactivity (<15% positive cells; score 0) in most tumors. The remaining 13% had surgery for tumors with more than 15% cells with positive staining (score I). There was no correlation between LeuM1 immunoreactivity and sex, age, and type of MTC. There was, however, a significant correlation with the pTNM classification and UICC staging. The prognosis for patients with score 0 was significantly better than score 1 patients. CD15 immunoreactivity appears to be a predictive factor in sporadic and hereditary MTC. Lymph node dissection seems to be more successful in patients with score 0 tumors than in those with score 1 tumors. The question of reoperation in patients with recurrence of disease (especially with biochemical recurrence or persistence) should be discussed on the basis of CD15 immunoreactivity.
Members and institutions are listed in Table 1. 相似文献
Resumen Los pacientes tratados para carcinoma medular, esporádico y hereditario, de la glándula tiroides (CMT) exhiben grandes variaciones en las tasas de enfermedad persistente, recidiva y sobrevida. El propósito del presente estudio fue establecer la correlación entre la inmunorreactividad del anticuerpo CD15 (LeuM1) y los hallazgos clínicos iniciales, así como con el resultado final del tratamiento.Se estudiaron los tumores primarios de 75 pacientes con CMT esporádico, de siete con enfermedad hereditaria y de 3 miembros de familias con síndrome NEM2A.Setenta y cuatro pacientes (87%) exhibieron ninguna o muy baja inmunorreactividad (menos de 15% de células positivas; puntaje 0) en la mayoría de los tumores. El 13% restante fue sometido a cirugía por tumores con más de 15% de las células con coloración positiva (puntaje 1). No se evidenció correlación entre la inmunorreactividad LeuM1 y el sexo, edad o tipo del CMT. Sin embargo, sí apareció una correlación significativa con la clasificiación pTNM y la estadificación de la UICC. El pronóstico de los pacientes con puntaje 0 resultó significativamento mejor que el de los pacientes con puntaje 1.La inmunorreactividad CD15 parece ser un factor de predicción de pronóstico en el CMT esporádico y familiar. La disección ganglionar parece ser más exitosa en pacientes con tumores de puntaje 0 que en los que portan tumores con puntaje 1.El interrogante en cuanto a reoperación en pacientes con recidiva de la enfermedad (especialmente cuando hay recidiva o persistencia bioquímica) debe ser considerada con base en la inmunorreactividad CD15.
Résumé Les taux de maladie persistante, de récidive et de survie chez des patients traités pour cancer médullaire sporadique et héréditaire de la thyroïde (CMT) sont très variables. Le but de cette étude a été de corréler l'immunoréactivité des anticorps monoclonaux CD15 (LeuM1) à des données cliniques initiales et l'évolution finale du traitement des CMT. On a étudié 75 patients ayant un CMT primitif, sept ayant une maladie héréditaire, et trois membres d'une famille MEN 2A. Soixante quatre patients (87%) avaient peu ou pas d'immunoréactivité (moins de 15% de cellules positive: score = 0). Les 13% restants ont eu une chirurgie pour les tumeurs ayant un pourcentage > 15 (score = 1). Il n'y avait aucune corrélation entre l'immunoréactivité LeuM1 et le sexe, l'âge et le type de CMT. Il y avait, en revanche, une corrélation significative entre la classification pTMN et le stage UICC. Le pronostic des patients ayant un score = 0 était significativement meilleur que celui des patients ayant un score = 1. L'immunoréactivité CD15 apparaît comme étant un facteur pronostique des CMT. Le curage lymphatique
Members and institutions are listed in Table 1. 相似文献